The Use of Rituximab in Glomerulonephritis: What Is the Evidence?

Rituximab has been increasingly used as a choice of treatment in various forms of glomerulonephritis. Recent evidence and the KDIGO guideline establish Rituximab as the first-line treatment for Primary Membranous Nephropathy and ANCA-associated vasculitis. It is also recommended in cases of steroid-...

Full description

Bibliographic Details

Published in:	Biomedicines
Main Authors:	Wenjuan Zhu, Haiyan He, Pearl Pai
Format:	Article
Language:	English
Published:	MDPI AG 2025-09-01
Subjects:	rituximab glomerular disease nephrology
Online Access:	https://www.mdpi.com/2227-9059/13/9/2157